Clinical Trials Browser

Phase 2 × Lung Neoplasms × abemaciclib × Clear all

NCT04545710 2024-08-05

Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance

Phase 2 Active not recruiting

Lung Neoplasms